Zhiming Li

First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial

Xiaopeng Tian, Jun Cai, Yi Xia et al. · The Lancet Haematology · 2024 · 30 citations

Medicine, Oncology, Pharmacology +12

A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China

Weiping Liu, Donglu Zhao, Ting Liu et al. · Frontiers in Oncology · 2021 · 22 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Distinct clinical and genetic features of hepatitis B virus–associated follicular lymphoma in Chinese patients

Weicheng Ren, Xianhuo Wang, Ming‐Yu Yang et al. · Blood Advances · 2022 · 20 citations · Full text

Life Sciences, Oncology, Pathology +14

The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis

Yanxia He, Yan Gao, Liqin Ping et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 20 citations · Full text

Medicine, Hematology, Oncology +14

Diagnostic performance and prognostic value of circulating tumor DNA methylation marker in extranodal natural killer/T cell lymphoma

Xiao‐Peng Tian, Yuchen Zhang, Ningjing Lin et al. · Cell Reports Medicine · 2023 · 20 citations · Full text

Medicine, Oncology, Pathology +17